Ricardo Menegatti | Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Ricardo Menegatti | Pharmaceutical Science | Best Researcher Award

Associate Professor and UFG, Brazil

Assoc. Prof. Dr. Ricardo Menegatti is an Associate Professor at the Faculty of Pharmacy, Federal University of Goiás (UFG), Brazil. His academic journey began with a Bachelor’s degree in Pharmacy from the Federal University of Santa Catarina (UFSC), followed by a Master’s degree in Chemistry and a Ph.D. in Chemistry from the Federal University of Rio de Janeiro (UFRJ). His doctoral research focused on the design, synthesis, and pharmacological evaluation of novel neuroactive drug prototypes. Dr. Menegatti’s expertise spans various aspects of medicinal chemistry, including the development of new pharmacological agents, medicinal chemistry, and pharmaceutical analysis. He has been actively involved in teaching and research since joining UFG in 2006, where he has contributed to the development of courses in medicinal chemistry, pharmaceutical analysis, and organic chemistry. His work also includes extensive contributions to the university’s extension activities, such as coordinating workshops and seminars on pharmaceutical chemistry. Dr. Menegatti has a robust record of publications and presentations in his field, and his research interests primarily revolve around the synthesis of novel pharmacological agents and the application of advanced chemical techniques in drug development.

Profile
Education

Dr. Ricardo Menegatti holds a distinguished educational background in the field of pharmacy and chemistry. He earned his Bachelor’s degree in Pharmacy from the Federal University of Santa Catarina (UFSC) in 1998, where his research focused on leprosy. He then pursued advanced studies at the Federal University of Rio de Janeiro (UFRJ), obtaining a Master’s degree in Chemistry in 2001. His master’s research, under the guidance of Eliezer Jesus Barreiro, involved the design, synthesis, and pharmacological evaluation of new antipsychotic drug candidates, specifically targeting schizophrenia. Dr. Menegatti further advanced his expertise by completing a Ph.D. in Chemistry at UFRJ in 2005, focusing on the planning, synthesis, and pharmacological assessment of neuroactive drug prototypes, particularly in the areas of GABA, hypnotics, and analgesics. His doctoral research, also mentored by Eliezer J. Barreiro, was supported by the National Council for Scientific and Technological Development (CNPq), reflecting his commitment to advancing pharmaceutical sciences.

Professional Experience

Dr. Ricardo Menegatti is a seasoned academic and researcher with a strong background in pharmaceutical chemistry and medicinal compounds. He holds a Doctorate in Chemistry from the Federal University of Rio de Janeiro, where his research focused on the design, synthesis, and pharmacological evaluation of neuroactive drug prototypes. Dr. Menegatti currently serves as a Professor at the Faculty of Pharmacy, Federal University of Goiás, Brazil, where he has been a dedicated faculty member since 2006. His expertise lies in planning and synthesizing biologically active compounds, particularly those targeting neuroactive and antipsychotic pathways. In addition to his teaching responsibilities, Dr. Menegatti is actively involved in graduate-level mentoring, guiding students in the Biological Sciences postgraduate program. His contributions extend to organizing workshops, coordinating seminars, and participating in extension activities, reflecting his commitment to advancing pharmaceutical education and research.

Research Interests

Dr. Ricardo Menegatti’s research interests lie at the intersection of pharmaceutical chemistry and medicinal chemistry, with a particular focus on the design, synthesis, and pharmacological evaluation of biologically active compounds. His work primarily revolves around the development of neuroactive drug prototypes, targeting the GABAergic system to explore potential treatments for neurological disorders such as schizophrenia, anxiety, and sleep disorders. Additionally, Dr. Menegatti is engaged in the discovery of new analgesic and antipsychotic agents, leveraging his expertise in molecular modeling and structure-activity relationships (SAR) to enhance drug efficacy and safety. His research also extends to the use of solid-phase synthesis and enzymatic catalysis in drug development, aiming to innovate in the creation of new therapeutic agents. Through his work, Dr. Menegatti contributes to the advancement of medicinal chemistry, striving to address critical challenges in the treatment of mental health disorders.

Awards and Recognition

Dr. Menegatti’s academic and research excellence has been recognized through various awards and honors throughout his career. As a recipient of scholarships from the National Council for Scientific and Technological Development (CNPq) in Brazil, he has demonstrated a strong commitment to advancing scientific knowledge. His leadership in organizing workshops and seminars further highlights his contributions to the academic community, earning him recognition among his peers and students.

Conclusion

Dr. Ricardo Menegatti’s extensive research contributions in medicinal chemistry, particularly in the development of neuroactive and antipsychotic drug candidates, make him a strong candidate for the Research for Best Researcher Award. His work has a significant geographic impact, with potential applications in global healthcare. While his research is primarily focused on pharmaceutical sciences, its implications extend to broader areas such as infectious diseases. Dr. Menegatti’s collaborative efforts, applied research, and academic leadership further solidify his suitability for this prestigious award.

Publications Top Notes

LQFM289: Electrochemical and Computational Studies of a New Trimetozine Analogue for Anxiety Treatment

  • Journal: International Journal of Molecular Sciences
  • Date: September 26, 2023
  • DOI: 10.3390/ijms241914575

Bioanalytical LC-QTOF/MS Method for a N-phenylpiperazine Derivate (LQFM05): An Anxiolytic- and Antidepressant-like Prototype Drug Applied to Pharmacokinetic and Biodistribution Studies

Antileishmanial Activity of the Chalcone Derivative LQFM064 Associated with Reduced Fluidity in the Parasite Membrane as Assessed by EPR Spectroscopy

Toxico-Pharmacological Evaluations of the Small-Molecule LQFM166: Inducer of Apoptosis and MDM2 Antagonist

 

Dr. Victoria Ramos | Smart Health | Global Health Impact Award

Posted on by ScienceFather

Dr. Victoria Ramos | Smart Health | Global Health Impact Award

Científica Titular de OPI at Smart Health , Instituto de Salud Carlos III , Spain

👨‍🎓She remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 She successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

A. Previous Activities: They served as the Chief of the Geology Service (Petrography – Mineralogy) at the Regional Laboratory of the Mining Research Company, South Division, Tamanrasset, in 1988 and 1989. B. Recruitment at the University: They were recruited on September 11, 1989, as a Teacher in the Department of Geology at the Faculty of Earth Sciences.

Activities:

In the classic system (1989-2010):

  • Fundamental Geochemistry
  • Petrology of Metamorphic Terrains
  • Mineralogy
  • Thermodynamics

In the LMD system (since 2010):

  • Bachelor’s Level:
    • Global Geodynamics and Metamorphism
    • Geochemistry of the Earth
    • Geochemistry of Natural Gases and Organic Geochemistry
    • Stable Isotopes

Administrative:

  • Acting as the Head of the Mining Geology Department
  • Overseeing field internships for students
  • Participating in several university research projects (Project No. G2301/01/91 from 1991 to 1995; Project No. G2301/05/98 from 1998 to 2000; Project No. F2301/02/2002 from 2001 to 2005)
  • Leading the research project with the code G2301/09/2005, as well as three other projects since 2005
  • Serving as a member of the organizing committee for the Maghreb Seminar on Earth Sciences at the University of Annaba in 1994
  • Being involved in the ANDRS research project from 2000 to 2004
  • Acting as a member of the scientific committee for the National Seminar on Earth Sciences in Tlemcen, October 199

Publications:

Serum interleukin-6 levels predict kidney disease progression in diabetic nephropathy

The Impact of Cardiac Lipotoxicity on Cardiac Function and Mirnas Signature in Obese and Non-Obese Rats with Myocardial Infarction

Aldosterone Impairs Mitochondrial Function in Human Cardiac Fibroblasts via A-Kinase Anchor Protein

Galectin-3 down-regulates antioxidant peroxiredoxin-4 in human cardiac fibroblasts: A new pathway to induce cardiac damage

A role for fumarate hydratase in mediating oxidative effects of galectin-3 in human cardiac fibroblasts

Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity

Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats

MPGES-1 (Microsomal prostaglandin E synthase-1) mediates vascular dysfunction in hypertension through oxidative stress

The impact of obesity in the cardiac lipidome and its consequences in the cardiac damage observed in obese rats | El impacto de la obesidad sobre el lipidoma cardiaco y sus consecuencias en el daño cardiaco en ratas obesas

The role of oxidative stress in the crosstalk between leptin and mineralocorticoid receptor in the cardiac fibrosis associated with obesity

Mr. Waseem Ali | Drug Repurposing | Best Researcher Award

Posted on by ScienceFather

Mr. Waseem Ali : Leading Researcher in Drug Repurposing

PhD Student at Drug Repurposing, Guru Nanak Dev Engineering College, Ludhiana, Punjab, India

He remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 He successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

Mr. Waseem Ali achieved academic success throughout his educational journey. In 2011, he secured a First Division in the Matriculation examination from the C.B.S.E. Board, India, with a focus on Science. Continuing his impressive performance, he obtained a Second Division in the Higher Secondary examination in 2013 from the same board. In 2016, he graduated with a Second Division from C.C.S. University, Meerut, specializing in Biotechnology with a focus on molecular biology. His commitment to excellence was further demonstrated in 2018 when he completed his Post Graduation with a First Division from Jamia Hamdard, New Delhi, specializing in Biotechnology with a focus on molecular biology.

Experience:

Mr. Waseem Ali has held several positions in the field of Biotechnology and molecular biology. From 05-08-2022 to 29-12-2022, he served as a Project Assistant at Jamia Hamdard, where he contributed to a project aiming to decipher novel targets of M.tb pathogenesis that manipulate host defenses in compromised hosts. The identified targets may be utilized to develop anti-TB agents effective against drug-resistant isolates. His supervisor during this time was Dr. Javaid A Shaikh. Prior to this, from 15-01-2019 to 04-08-2022, Mr. Ali worked as a Project Assistant at Jamia Hamdard, focusing on determining the effect of FDA-approved drugs against M.tb. He evaluated the efficacy of selected drugs against M.tb in vitro and ex vivo, using molecular docking, simulation, and biophysical methods to predict their binding affinity and effect with target proteins. His supervisors during this period were Prof. S. E. Hasnain and Dr. Sonam Grover. Currently, since 04-01-2021, Mr. Ali is pursuing his Ph.D. at Jamia Hamdard under the guidance of Prof. S. E. Hasnain and Dr. Sonam Grover, focusing on research related to drug repurposing.

Publications:

Mr. Waseem Ali has co-authored several research papers in reputable journals. In “Microbes and Infection” in 2023, he collaborated with Salma Jamal, Rishabh Gangwar, Faraz Ahmed, Isha Pahuja, Rahul Sharma, Ved Prakash Dwivedi, Meetu Agarwa, and Sonam Grover on a paper titled “Unravelling the potential of Triflusal as an anti-TB repurposed drug by targeting replication protein DciA,” which was published on 5.8. In “Molecular Informatics” in 2023, he worked with Salma Jamal, Rishabh Gangwar, Faraz Ahmed, Rahul Sharma, Meetu Agarwal, Javaid Ahmad Sheikh, Abhinav Grover, and Sonam Grover on a paper titled “Targeting of essential mycobacterial replication enzyme DnaG primase revealed Mitoxantrone and Vapreotide as novel mycobacterial growth inhibitors,” which was published on 4.05. Additionally, in “Computational and Structural Biotechnology Journal” in 2021, he contributed to a paper titled “Computational modeling and bioinformatic analyses of functional mutations in drug target genes in Mycobacterium tuberculosis,” co-authored with Pooja Singh, Salma Jamal, Faraz Ahmed, Najumu Saqib, Seema Mehra, Deodutta Roy, Nasreen Z Ehtesham, and Seyed E Hasnain. In “Journal of Translational Medicine” in 2021, Mr. Ali collaborated with Salma Jamal, Priya Nagpal, Abhinav Grover, and Sonam Grover on a paper titled “Computational models for the prediction of adverse cardiovascular drug reactions,” which was published on 8.44.

 

Mr. Rahul Sharma | Molecular Medicine | Best Researcher Award

Posted on by ScienceFather

Mr. Rahul Sharma : Leading Researcher in Molecular Medicine

PhD Scholar at Molecular Medicine, Jamia Hamdard, India

He remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 He successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

Mr. Rahul Sharma is a dedicated researcher with expertise in molecular medicine and biotechnology. In 2023, he submitted his Ph.D. thesis in Molecular Medicine at Jamia Hamdard, New Delhi. His research focused on drug repurposing approaches against methyltransferases of Mycobacterium tuberculosis and alternative therapeutics, under the supervision of Dr. Sonam Grover. Prior to his Ph.D., Mr. Sharma completed his MS in Biotechnology at Jamia Hamdard in 2017. His master’s thesis titled “Molecular characterization and phylogenetic analysis of Rotavirus A, G9 with different P-type combinations including Rotavac vaccine strain G9P[11], 116E” was conducted under the guidance of Professor Pratima Ray. His academic journey reflects a strong commitment to advancing knowledge in the field of molecular medicine and biotechnology. Mr. Rahul Sharma is a researcher specializing in molecular medicine and biotechnology. In 2023, he completed his Ph.D. in Molecular Medicine at Jamia Hamdard, New Delhi, where he focused on drug repurposing approaches against methyltransferases of Mycobacterium tuberculosis and alternative therapeutics. This significant research was conducted under the guidance of Dr. Sonam Grover. Prior to his Ph.D., Mr. Sharma earned his MS in Biotechnology from Jamia Hamdard in 2017. His master’s thesis, supervised by Professor Pratima Ray, was titled “Molecular characterization and phylogenetic analysis of Rotavirus A, G9 with different P-type combinations including Rotavac vaccine strain G9P[11], 116E.” Mr. Sharma’s academic journey showcases his dedication to advancing the field of molecular medicine and biotechnology through rigorous research.

Experience:

In his primary research work, Mr. Rahul Sharma conducted screenings of FDA-approved drugs using computational and biophysical methods against essential enzymes of Mycobacterium tuberculosis. Selected compounds from this screening were then tested for their inhibitory potential on the virulent strain Mtb-H37Rv under both in-vitro and ex-vivo conditions. In his secondary research work, Mr. Sharma focused on immunoinformatics to design a vaccine construct aimed at preventing and treating Mycobacterium tuberculosis infections. This vaccine construct was designed based on the analysis of secretory exosomes antigens of the pathogen, with the goal of developing a preventive therapeutic approach against tuberculosis.

Area of Specialization:

  1. Molecular Cloning
  2. Recombinant protein production
  3. Fluorescence spectroscopy
  4. High-throughput ligand and buffer screening
  5. Protein-ligand interaction thermodynamics
  6. Protein folding and unfolding
  7. Molecular dynamic simulations
  8. Computational Structure-based drug design
  9. Molecular mechanical calculations
  10. Peptide-based vaccine design

Technical skills:

Mr. Rahul Sharma demonstrates proficiency in a variety of technical skills relevant to his research in molecular medicine and biotechnology:

  • Operating Systems: He is experienced in working with UNIX (Ubuntu) and Windows operating systems, showcasing adaptability across different platforms.
  • Programming Languages: He has a foundational understanding of Bash and Python programming languages, which are commonly used in bioinformatics and computational biology.
  • Molecular Dynamics: Mr. Sharma has expertise in using GROMACS for simulating protein-ligand and protein-protein interactions, as well as DESMOND for molecular dynamics simulations.
  • Docking Software: He is skilled in using GLIDE and VINA for molecular docking studies, a crucial aspect of drug discovery and development.
  • Purification Techniques: Mr. Sharma is proficient in the use of Nickel-NTA His-tag affinity chromatography for protein purification, a key step in obtaining high-quality protein samples.

Awards:

Mr. Rahul Sharma has received prestigious accolades and awards that underscore his exceptional contributions and achievements in the field of biotechnology and molecular medicine:

  • 2020 Senior Research Fellowship (SRF), Department of Biotechnology, Government of India: Recognition of his advanced research capabilities and significant contributions to the field, awarded by the esteemed Department of Biotechnology, Government of India.
  • 2018 Junior Research Fellowship (JRF), Department of Biotechnology, Government of India: Acknowledgment of his research potential and early accomplishments in the field, awarded by the Department of Biotechnology, Government of India.
  • 2018 Award for Assistant Professorship, Agricultural Scientists Recruitment Board (ASRB), Government of India: Recognition of his potential for an academic career and teaching excellence, awarded by the Agricultural Scientists Recruitment Board (ASRB), Government of India.